Buy Strides Pharma; target of Rs 930: Motilal Oswal
Motilal Oswal is bullish on Strides Pharma recommended buy rating on the stock with a target price of Rs 930 in its research report dated May 28, 2021.
Stock Analysis
This stock rose 46% in a week, hit 52-week high today
The share stood at Rs 93.95 on June 1, 2020 on BSE. It has zoomed to Rs 262.85 today, translating into gains of 180 per cent during the period.
Motherson Sumi shares up 1.23% as Nifty gains
A total of 225,225 shares changed hands on the counter till 12:35PM (IST).
GLD Gains Ground Against Bitcoin
GLD is down by more than -8.6% since August 6th, 2020. Click here to read which asset class – Gold or Bitcoin – does better.
Asian stocks lower after Wall St ends May with gains
Asian stock markets have fallen after Japan reported weaker-than-expect growth in factory output and Chinese manufacturing growth was flat
Monday’s Best Deals: Apple AirPods, 60% Mechanical Gaming Keyboard, Cuisinart Charcoal Grill, EltaMD UV Physical Tinted Face Sunscreen, and More
Jump to: Tech | Gaming | Home | Lifestyle | MediaRead more…
Asian stocks lower after Wall St ends May with gains
BEIJING (AP) — Asian stock markets fell Monday after Japan reported weaker-than-expect growth in factory output and Chinese manufacturing growth was f…
Asian stocks lower after Wall St ends May with gains
Asian stock markets have fallen after Japan reported weaker-than-expect growth in factory output and Chinese manufacturing growth was flat
Asian stocks lower after Wall St ends May with gains
Asian stock markets fell Monday after Japan reported weaker-than-expect growth in factory output and Chinese manufacturing growth was flat. On Wall Street, …
Pinterest: A Stock We Own For The Long Term
Pinterest is poised to benefit from strong buying intent of its user base. Read more to know why we expect MAU growth to come back strongly later this and early…